Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Ryan Elder likely killed his mother because he lost his temper, not because he believed his life was at risk, the Crown said ...

Schizophrenia is perhaps the human condition,” wrote Tim Crow in 2000.1 Crow had been researching schizophrenia for most of his psychiatric career but the origins of this most complex condition had ...

Bridgeport killer cannibal Tyree Smith, up for review by the Psychiatric Security Review Board, isn't the only recent ...

Community Health Network this week announced a joint venture with a unit of Tennessee-based health services company Lifepoint ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.

At one point in the past, one local mother said she spent 24 hours in an ER waiting room. Now, at Connections Kirkland, she ...

Community Health Network this week announced a joint venture with a unit of Tennessee-based health services company Lifepoint Health to build two 120-bed inpatient hospitals in the Indianapolis area, ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

Indirect funds are essential for supporting the research infrastructure needed to develop innovative solutions to the most ...

A $150,000 grant has been awarded to Pignanelli Partners to launch the Center for Arts Therapies & Creative Healing ...